Determinants of Oligonucleotide Selectivity of APOBEC3B
暂无分享,去创建一个
Rommie E. Amaro | Rommie E Amaro | Jeffrey R Wagner | Özlem Demir | Michael A Carpenter | Hideki Aihara | Daniel A Harki | Reuben S Harris | M. Carpenter | R. Amaro | Ö. Demir | D. Harki | H. Aihara | Daniel A. Harki | R. Harris | J. Wagner | Özlem Demir
[1] C. Simmerling,et al. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. , 2015, Journal of chemical theory and computation.
[2] Huijue Jia,et al. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation , 2012, Nature chemical biology.
[3] Benjamin Haibe-Kains,et al. APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation , 2015, Proceedings of the National Academy of Sciences.
[4] Rommie E. Amaro,et al. POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics , 2014, Journal of chemical theory and computation.
[5] H. Aydin,et al. Structure-guided analysis of the human APOBEC3-HIV restrictome. , 2014, Structure.
[6] Lela Lackey,et al. Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination , 2013, Cell cycle.
[7] Rommie E. Amaro,et al. Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B , 2016, Nature Structural &Molecular Biology.
[8] Rommie E. Amaro,et al. Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B , 2017, Scientific Reports.
[9] R. Kohli,et al. Nucleic acid determinants for selective deamination of DNA over RNA by activation-induced deaminase , 2013, Proceedings of the National Academy of Sciences.
[10] K Nadassy,et al. Structural features of protein-nucleic acid recognition sites. , 1999, Biochemistry.
[11] Michael Emerman,et al. HIV-1 accessory proteins--ensuring viral survival in a hostile environment. , 2008, Cell host & microbe.
[12] Jacob D. Durrant,et al. POVME: an algorithm for measuring binding-pocket volumes. , 2011, Journal of molecular graphics & modelling.
[13] R. Harris,et al. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer , 2016, Genome Biology.
[14] M. Carpenter,et al. Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain* , 2015, The Journal of Biological Chemistry.
[15] S. Ranganathan,et al. Advances in RNA molecular dynamics: a simulator's guide to RNA force fields , 2017, Wiley interdisciplinary reviews. RNA.
[16] D. Harki,et al. APOBEC Enzymes as Targets for Virus and Cancer Therapy. , 2017, Cell chemical biology.
[17] Steven A. Roberts,et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.
[18] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[19] Rommie E. Amaro,et al. The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution. , 2013, Journal of molecular biology.
[20] M. Sundaralingam,et al. Conformational analysis of the sugar ring in nucleosides and nucleotides. A new description using the concept of pseudorotation. , 1972, Journal of the American Chemical Society.
[21] Z. Szallasi,et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.
[22] T. Cheatham,et al. Molecular Modeling of Nucleic Acid Structure , 2001, Current protocols in nucleic acid chemistry.
[23] Serena Nik-Zainal,et al. Mechanisms underlying mutational signatures in human cancers , 2014, Nature Reviews Genetics.
[24] C. Schiffer,et al. Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3A* , 2012, The Journal of Biological Chemistry.
[25] N. A. Temiz,et al. APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.
[26] Reuben S Harris,et al. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer , 2016, Science Advances.
[27] R. Gordân,et al. Protein–DNA binding: complexities and multi-protein codes , 2013, Nucleic acids research.
[28] Jason B. Nikas,et al. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. , 2013, Cancer research.
[29] H. Matsuo,et al. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G , 2008, Nature.
[30] C. Schiffer,et al. Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity , 2017, Nature Communications.
[31] B. Honig,et al. A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.
[32] Thomas J Lane,et al. MDTraj: a modern, open library for the analysis of molecular dynamics trajectories , 2014, bioRxiv.
[33] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[34] Z. Xiang,et al. On the role of the crystal environment in determining protein side-chain conformations. , 2002, Journal of molecular biology.
[35] C. Swanton,et al. Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] Claudio N. Cavasotto,et al. Open challenges in structure-based virtual screening: Receptor modeling, target flexibility consideration and active site water molecules description. , 2015, Archives of biochemistry and biophysics.
[37] Stefano Piana,et al. Assessing the accuracy of physical models used in protein-folding simulations: quantitative evidence from long molecular dynamics simulations. , 2014, Current opinion in structural biology.
[38] A. Gronenborn,et al. Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity. , 2016, Biochemistry.
[39] E. Pinatel,et al. Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines , 2017, Leukemia.
[40] Ming Li,et al. Small‐Molecule APOBEC3G DNA Cytosine Deaminase Inhibitors Based on a 4‐Amino‐1,2,4‐triazole‐3‐thiol Scaffold , 2013, ChemMedChem.
[41] Jan H. Jensen,et al. PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. , 2011, Journal of chemical theory and computation.
[42] C. Schiffer,et al. A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif. , 2014, Virology.
[43] Rebecca M. McDougle,et al. D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B. , 2013, Virology.
[44] Fumiaki Ito,et al. DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B , 2015, The Biochemical journal.
[45] J. Šponer,et al. Can We Execute Stable Microsecond-Scale Atomistic Simulations of Protein-RNA Complexes? , 2015, Journal of chemical theory and computation.
[46] E. Baker,et al. Hydrogen bonding in globular proteins. , 1984, Progress in biophysics and molecular biology.
[47] J. Šponer,et al. Refinement of the AMBER Force Field for Nucleic Acids: Improving the Description of α/γ Conformers , 2007 .
[48] Andreas Schlicker,et al. Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers , 2014, Hormones and Cancer.
[49] Yi Xiao,et al. RNA Stability Under Different Combinations of Amber Force Fields and Solvation Models , 2010, Journal of biomolecular structure & dynamics.
[50] Sophia Kossida,et al. Current state-of-the-art molecular dynamics methods and applications. , 2014, Advances in protein chemistry and structural biology.
[51] Daniel R Roe,et al. PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. , 2013, Journal of chemical theory and computation.
[52] Gordon Cook,et al. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma , 2014, Nature Communications.
[53] Yuan-feng Yang,et al. High APOBEC3B expression is a predictor of recurrence in patients with low-risk clear cell renal cell carcinoma. , 2015, Urologic oncology.
[54] P. V. van Diest,et al. Progressive APOBEC3B mRNA expression in distant breast cancer metastases , 2017, PloS one.
[55] R. Maul,et al. A Portable Hot Spot Recognition Loop Transfers Sequence Preferences from APOBEC Family Members to Activation-induced Cytidine Deaminase* , 2009, The Journal of Biological Chemistry.
[56] M. Carpenter,et al. Determinants of sequence-specificity within human AID and APOBEC3G. , 2010, DNA repair.
[57] S. Schneider,et al. Making the Bend: DNA Tertiary Structure and Protein-DNA Interactions , 2014, International journal of molecular sciences.
[58] A. Bhagwat,et al. Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases. , 2016, Chemical reviews.
[59] N. A. Temiz,et al. Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.
[60] Luca Pinello,et al. An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities , 2018, Nature Biotechnology.
[61] M. Neuberger,et al. Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID , 2010, The Journal of experimental medicine.
[62] Nicholas M. Luscombe,et al. Amino acid?base interactions: a three-dimensional analysis of protein?DNA interactions at an atomic level , 2001, Nucleic Acids Res..
[63] N. Krogan,et al. First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G. , 2012, ACS chemical biology.
[64] A. Bhagwat,et al. Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G , 2012, Nucleic acids research.
[65] Subha Kalyaanamoorthy,et al. Modelling and enhanced molecular dynamics to steer structure-based drug discovery. , 2014, Progress in biophysics and molecular biology.
[66] W. Brown,et al. A fluorescent reporter for quantification and enrichment of DNA editing by APOBEC–Cas9 or cleavage by Cas9 in living cells , 2018, Nucleic acids research.
[67] R. Harris,et al. Impact of H216 on the DNA Binding and Catalytic Activities of the HIV Restriction Factor APOBEC3G , 2013, Journal of Virology.
[68] Rommie E. Amaro,et al. POVME 3.0: Software for Mapping Binding Pocket Flexibility. , 2017, Journal of chemical theory and computation.
[69] Holger Gohlke,et al. The Amber biomolecular simulation programs , 2005, J. Comput. Chem..
[70] R. Siebert,et al. Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma , 2015, Leukemia.
[71] S. Wain-Hobson,et al. Efficient Deamination of 5-Methylcytidine and 5-Substituted Cytidine Residues in DNA by Human APOBEC3A Cytidine Deaminase , 2013, PloS one.
[72] V. Pathak,et al. The Role of Amino-Terminal Sequences in Cellular Localization and Antiviral Activity of APOBEC3B , 2011, Journal of Virology.
[73] J. Dudley,et al. APOBECs and virus restriction. , 2015, Virology.
[74] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[75] F. J. Luque,et al. Dynamics of B-DNA on the microsecond time scale. , 2007, Journal of the American Chemical Society.
[76] Jan H. Jensen,et al. Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values. , 2011, Journal of chemical theory and computation.
[77] H. Matsuo,et al. Two Regions within the Amino-Terminal Half of APOBEC3G Cooperate To Determine Cytoplasmic Localization , 2008, Journal of Virology.
[78] E. Paquet,et al. Molecular Dynamics, Monte Carlo Simulations, and Langevin Dynamics: A Computational Review , 2015, BioMed research international.